Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V

There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes in P. falciparum populations in Nigeria, but one previous study has recorded a novel dhps mutation at codon 431 among infections imported to the United Kingdom from Nigeria. To...

Full description

Bibliographic Details
Main Authors:	Mary C. Oguike, Catherine O. Falade, Elvis Shu, Izehiuwa G. Enato, Ismaila Watila, Ebenezer S. Baba, Jane Bruce, Jayne Webster, Prudence Hamade, Sylvia Meek, Daniel Chandramohan, Colin J. Sutherland, David Warhurst, Cally Roper
Format:	Article
Language:	English
Published:	Elsevier 2016-12-01
Series:	International Journal for Parasitology: Drugs and Drug Resistance
Subjects:	Sulfadoxine-pyrimethamine dhps dhfr mutations Nigeria
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211320716300197

Similar Items

Markers of sulfadoxine–pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention
by: Marit van Lenthe, et al.
Published: (2019-12-01)

Plasmodium falciparum Genetic Diversity and Resistance Genotype Profile in Infected Placental Samples Collected After Delivery in Ouagadougou
by: Sawadogo H, et al.
Published: (2023-10-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.

Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Pregnancy: Low Coverage and High Prevalence of <i>Plasmodium falciparum</i> dhfr-dhps Quintuple Mutants as Major Challenges in Douala, an Urban Setting in Cameroon
by: Carole Else Eboumbou Moukoko, et al.
Published: (2023-06-01)

Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria
by: Rachmawati Rachmawati, et al.
Published: (2010-04-01)

Efficacy of Pyrimethamine/Sulfadoxine Versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years
by: H Chen, et al.
Published: (2013-03-01)

Efficacy of Pyrimethamine/Sulfadoxine versus Chloroquine for the Treatment of Uncomplicated Falciparum Malaria in Children Aged Under 5 Years
by: W Zheng, et al.
Published: (2013-03-01)

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
by: Nimita Deora, et al.
Published: (2024-07-01)

The Comparative Effects of Antenatal Azithromycin and Sulfadoxine-pyrimethamine on Maternal Malaria during Pregnancy
by: Ganiyu Olanipekun Ahmed, et al.
Published: (2024-10-01)

Status of dhps and dhfr genes of Plasmodium falciparum in Colombia before artemisinin based treatment policy Estado de los genes dhps y dhfr de Plasmodium falciparum en Colombia antes de la recomendación de tratamiento basado en artemisinina
by: Andrés Villa, et al.
Published: (2012-03-01)

High prevalence of genotypes associated with sulfadoxine/pyrimethamine resistance in the rural area of Fougamou, Gabon
by: Fleuramie Mirembou Boukoumba, et al.
Published: (2021-06-01)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
by: Alexandra T. Roux, et al.
Published: (2021-06-01)

Comparative efficacy of chloroquine and pyrimethamine-sulfadoxine versus artemether and pyrimethamine-sulfadoxine in the treatment of uncomplicated falciparum malaria in children
by: Femmy Tambajong, et al.
Published: (2016-10-01)

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
by: Jean Claude Djontu, et al.
Published: (2024-12-01)

Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing
by: Jeremiah M. Ngondi, et al.
Published: (2017-06-01)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
by: Philippe Deloron, et al.
Published: (2010-11-01)

Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016–2017
by: Eric Rogier, et al.
Published: (2020-05-01)

Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to <it>Plasmodium falciparum </it>in Mozambican Children
by: Quelhas Diana, et al.
Published: (2012-01-01)

Intermittent preventive treatment of malaria in pregnancy: a cross-sectional survey to assess uptake of the new sulfadoxine–pyrimethamine five dose policy in Ghana
by: Ivy Owusu-Boateng, et al.
Published: (2017-08-01)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
by: Esmée Ruizendaal, et al.
Published: (2017-04-01)

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru
by: Alan J. Magill, et al.
Published: (2004-06-01)

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]
by: Palmer M. Netongo, et al.
Published: (2024-06-01)

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023-01-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania
by: George M. Bwire, et al.
Published: (2020-07-01)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
by: Ashish Pathak, et al.
Published: (2020-08-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01)

Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in <it>Plasmodium falciparum</it> parasites from pregnant women in western Kenya
by: Iriemenam Nnaemeka C, et al.
Published: (2012-07-01)

Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01)

Frequency of Pfcrt T76 and Pfdhfr Asn-108 Drug Resistance Mutations in falciparum Malaria in Southeastern Malaria Endemic Area of Iran
by: MR Razavi, et al.
Published: (2008-03-01)

Frequency of Pfcrt T76 and Pfdhfr Asn-108 Drug Resistance Mutations in falciparum Malaria in Southeastern Malaria Endemic Area of Iran
by: MR Razavi, et al.
Published: (2008-05-01)

Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial
by: Abel Kakuru, et al.
Published: (2020-08-01)

Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
by: A Sowunmi, et al.
Published: (2005-07-01)

Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan
by: Irene Molina-de la Fuente, et al.
Published: (2023-11-01)

Comparative evaluation of the efficacy of chloroquine and sulphadoxine-pyrimethamine in the treatment of uncomplicated Malaria in children under five years in a Rural population of Enugu State
by: Henrietta U Okafor, et al.
Published: (2004-01-01)

Direct therapeutic effect of sulfadoxine-pyrimethamine on nutritional deficiency-induced enteric dysfunction in a human Intestine ChipResearch in context
by: Seongmin Kim, et al.
Published: (2024-01-01)

Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015–2016 Tanzania demographic and health survey and malaria indicator survey
by: Vivian Mushi, et al.
Published: (2021-02-01)

Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018
by: Angela Patricia Guerra, et al.
Published: (2022-10-01)

Women’s empowerment and uptake of sulfadoxine–pyrimethamine for intermittent preventive treatment of malaria during pregnancy: results from a cross-sectional baseline survey in the Lake endemic region, Kenya
by: George Odwe, et al.
Published: (2023-08-01)